The effect of IL-10 genetic variation and interleukin 10 serum levels on Crohn's disease susceptibility in a New Zealand population

Human Immunology

Volumn 72, Issue 5, 2011, Pages 431-435

  Wang, Alice H ^a,b   Lam, Wen Jiun ^a,b   Han, Dug Yeo ^a,b   Ding, Yaoyao ^a,b   Hu, Rong ^a,b   Fraser, Alan G ^a   Ferguson, Lynnette R ^a,b   Morgan, Angharad R ^a,b  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b Nutrigenomics New Zealand   (New Zealand)

Author keywords

Crohn's disease; Genetic association; IL 10

Indexed keywords

INTERLEUKIN 10;

ADOLESCENT; ADULT; ALLELE; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; CROHN DISEASE; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; NEW ZEALAND; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AGE OF ONSET; CROHN DISEASE; DISEASE PROGRESSION; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERLEUKIN-10; NEW ZEALAND; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC;

EID: 79954605781     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2011.02.014     Document Type: Article

References (29)

1. Moore K.W., de Waal Malefyt R., Coffman R.L., O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001, 19:683-765.
2. Kuhn R., Lohler J., Rennick D., Rajewsky K., Muller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993, 75:263-274.
3. Fernandez L., Martinez A., Mendoza J.L., Urcelay E., Fernandez-Arquero M., Garcia-Paredes J., et al. Interleukin-10 polymorphisms in Spanish patients with IBD. Inflamm Bowel Dis 2005, 11:739-743.
4. Tagore A., Gonsalkorale W.M., Pravica V., Hajeer A.H., McMahon R., Whorwell P.J., et al. Interleukin-10 (IL-10) genotypes in inflammatory bowel disease. Tissue Antigens 1999, 54:386-390.
5. Aithal G.P., Craggs A., Day C.P., Welfare M., Daly A.K., Mansfield J.C., et al. Role of polymorphisms in the interleukin-10 gene in determining disease susceptibility and phenotype in inflammatory bowel disease. Dig Dis Sci 2001, 46:1520-1525.
6. Balding J., Livingstone W.J., Conroy J., Mynett-Johnson L., Weir D.G., Mahmud N., et al. Inflammatory bowel disease: the role of inflammatory cytokine gene polymorphisms. Mediat Inflamm 2004, 13:181-187.
7. Cantor M.J., Nickerson P., Bernstein C.N. The role of cytokine gene polymorphisms in determining disease susceptibility and phenotype in inflammatory bowel disease. Am J Gastroenterol 2005, 100:1134-1142.
8. Klein W., Tromm A., Griga T., Fricke H., Folwaczny C., Hocke M., et al. The IL-10 gene is not involved in the predisposition to inflammatory bowel disease. Electrophoresis 2000, 21:3578-3582.
9. Koss K., Satsangi J., Fanning G.C., Welsh K.I., Jewell D.P. Cytokine (TNF alpha, LT alpha and IL-10) polymorphisms in inflammatory bowel diseases and normal controls: differential effects on production and allele frequencies. Genes Immun 2000, 1:185-190.
10. Parkes M., Satsangi J., Jewell D. Contribution of the IL-2 and IL-10 genes to inflammatory bowel disease (IBD) susceptibility. Clin Exp Immunol 1998, 113:28-32.
11. Franke A., Balschun T., Karlsen T.H., Sventoraityte J., Nikolaus S., Mayr G., et al. Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility. Nat Genet 2008, 40:1319-1323.
12. Imielinski M., Baldassano R.N., Griffiths A., Russell R.K., Annese V., Dubinsky M., et al. Common variants at five new loci associated with early-onset inflammatory bowel disease. Nat Genet 2009, 41:1335-1340.
13. Lennard-Jones J.E. Classification of inflammatory bowel disease. Scand J Gastroenterol 1989, 170(suppl):2-6. [discussion:16-9].
14. Wigginton J.E., Cutler D.J., Abecasis G.R. A note on exact tests of Hardy-Weinberg equilibrium. Am J Hum Genet 2005, 76:887-893.
15. Sasieni P.D. From genotypes to genes: doubling the sample size. Biometrics 1997, 53:1253-1261.
16. Ihaka R., Gentleman R. R: a language for data analysis and graphics. J Comput Graph Stat 1996, 5:99-314.
17. Franke A., McGovern D.P., Barrett J.C., Wang K., Radford-Smith G.L., Ahmad T., et al. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat Genet 2010, 42:1118-1125.
18. Sanchez R., Levy E., Costea F., Sinnett D. IL-10 and TNF-alpha promoter haplotypes are associated with childhood Crohn's disease location. World J Gastroenterol 2009, 15:3776-3782.
19. Fowler E.V., Eri R., Hume G., Johnstone S., Pandeya N., Lincoln D., et al. TNFalpha and IL10 SNPs act together to predict disease behaviour in Crohn's disease. J Med Genet 2005, 42:523-528.
20. Comings D.E., MacMurray J.P. Molecular heterosis: a review. Mol Genet Metab 2000, 71:19-31.
21. Andersen V., Ernst A., Christensen J., Østergaard M., Jacobsen B.A., Tjønneland A., et al. The polymorphism rs3024505 proximal to IL-10 is associated with risk of ulcerative colitis and Crohns disease in a Danish case-control study. BMC Med Genet 2010, 11:82.
22. Kucharzik T., Stoll R., Lugering N., Domschke W. Circulating antiinflammatory cytokine IL-10 in patients with inflammatory bowel disease (IBD). Clin Exp Immunol 1995, 100:452-456.
23. Westendorp R.G., Langerman J.A., Huizinga T.W., Elouali A.H., Verweij C.L., Boomsma D.I., et al. Genetic influence on cytokine production and fatal meningococcal disease. Lancet 1997, 349:170-173.
24. Keijsers V., Verweij C.L., Westendorp R.G.J., Breedveld F.C., Huizinga T.W.J. IL-10 polymorphisms in relation to production and rheumatoid arthritis. Arthritis Rheum 1997, 40(suppl 9):S179.
25. Turner D.M., Williams D.M., Sankaran D., Lazarus M., Sinnott P.J., Hutchinson I.V. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 1997, 24:1-8.
26. Crawley E., Kay R., Sillibourne J., Patel P., Hutchinson I., Woo P. Polymorphic haplotypes of the interleukin-10 5' flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis. Arthritis Rheum 1999, 42:1101.
27. Suarez A., Castro P., Alonso R., Mozo L., Gutierrez C., Suarez A. Interindividual variations in constitutive interleukin-10 messenger RNA and protein levels and their association with genetic polymorphisms. Transplantation 2003, 75:711-717.
28. Wilson J.N., Rockett K., Jallow M., Pinder M., Sisay-Joof F., Newport M., et al. Analysis of IL10 haplotypic associations with severe malaria. Genes Immun 2005, 6:462-466.
29. Ouma C., Davenport G.C., Were T., Otieno M.F., Hittner J.B., Vulule J.M., et al. Haplotypes of IL-10 promoter variants are associated with susceptibility to severe malarial anemia and functional changes in IL-10 production. Hum Genet 2008, 124:515-524.